The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men - PubMed (original) (raw)
Clinical Trial
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
S Bhasin et al. N Engl J Med. 1996.
Free article
Abstract
Background: Athletes often take androgenic steroids in an attempt to increase their strength. The efficacy of these substances for this purpose is unsubstantiated, however.
Methods: We randomly assigned 43 normal men to one of four groups: placebo with no exercise; testosterone with no exercise; placebo plus exercise; and testosterone plus exercise. The men received injections of 600 mg of testosterone enanthate or placebo weekly for 10 weeks. The men in the exercise groups performed standardized weight-lifting exercises three times weekly. Before and after the treatment period, fat-free mass was determined by underwater weighing, muscle size was measured by magnetic resonance imaging, and the strength of the arms and legs was assessed by bench-press and squatting exercises, respectively.
Results: Among the men in the no-exercise groups, those given testosterone had greater increases than those given placebo in muscle size in their arms (mean [+/-SE] change in triceps area, 424 +/- 104 vs. -81 +/- 109 square millimeters; P < 0.05) and legs (change in quadriceps area, 607 +/- 123 vs. -131 +/- 111 square millimeters; P < 0.05) and greater increases in strength in the bench-press (9 +/- 4 vs. -1 +/- 1 kg, P < 0.05) and squatting exercises (16 +/- 4 vs. 3 +/- 1 kg, P < 0.05). The men assigned to testosterone and exercise had greater increases in fat-free mass (6.1 +/- 0.6 kg) and muscle size (triceps area, 501 +/- 104 square millimeters; quadriceps area, 1174 +/- 91 square millimeters) than those assigned to either no-exercise group, and greater increases in muscle strength (bench-press strength, 22 +/- 2 kg; squatting-exercise capacity, 38 +/- 4 kg) than either no-exercise group. Neither mood nor behavior was altered in any group.
Conclusions: Supraphysiologic doses of testosterone, especially when combined with strength training, increase fat-free mass and muscle size and strength in normal men.
Comment in
- The anabolic action of testosterone.
Bardin CW. Bardin CW. N Engl J Med. 1996 Jul 4;335(1):52-3. doi: 10.1056/NEJM199607043350111. N Engl J Med. 1996. PMID: 8637543 No abstract available.
Similar articles
- Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study.
Kvorning T, Andersen M, Brixen K, Madsen K. Kvorning T, et al. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1325-32. doi: 10.1152/ajpendo.00143.2006. Epub 2006 Jul 25. Am J Physiol Endocrinol Metab. 2006. PMID: 16868226 Clinical Trial. - Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy.
Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S. Sinha-Hikim I, et al. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E154-64. doi: 10.1152/ajpendo.00502.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12067856 Clinical Trial. - Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people.
Sullivan DH, Roberson PK, Smith ES, Price JA, Bopp MM. Sullivan DH, et al. J Am Geriatr Soc. 2007 Jan;55(1):20-8. doi: 10.1111/j.1532-5415.2006.01010.x. J Am Geriatr Soc. 2007. PMID: 17233681 Clinical Trial. - Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
Velema MS, Kwa BH, de Ronde W. Velema MS, et al. Curr Opin Pulm Med. 2012 Mar;18(2):118-24. doi: 10.1097/MCP.0b013e32834e9001. Curr Opin Pulm Med. 2012. PMID: 22189453 Review. - Proof of the effect of testosterone on skeletal muscle.
Bhasin S, Woodhouse L, Storer TW. Bhasin S, et al. J Endocrinol. 2001 Jul;170(1):27-38. doi: 10.1677/joe.0.1700027. J Endocrinol. 2001. PMID: 11431134 Review.
Cited by
- Harm reduction techniques among cisgender gay, bisexual, and queer men using anabolic androgenic steroids: a qualitative study.
Kutscher E, Arshed A, Greene RE, Kladney M. Kutscher E, et al. Harm Reduct J. 2024 Nov 11;21(1):196. doi: 10.1186/s12954-024-01121-8. Harm Reduct J. 2024. PMID: 39523302 Free PMC article. - The androgen receptor in mesenchymal progenitors regulates skeletal muscle mass via Igf1 expression in male mice.
Sakai H, Uno H, Yamakawa H, Tanaka K, Ikedo A, Uezumi A, Ohkawa Y, Imai Y. Sakai H, et al. Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2407768121. doi: 10.1073/pnas.2407768121. Epub 2024 Sep 18. Proc Natl Acad Sci U S A. 2024. PMID: 39292748 Free PMC article. - Testosterone supplementation and stroke in young adults: a review of the literature.
Dengri C, Koriesh A, Babi MA, Mayberry W, Goldstein ED, Pervez M, Nouh A. Dengri C, et al. Front Neurol. 2024 Sep 2;15:1422931. doi: 10.3389/fneur.2024.1422931. eCollection 2024. Front Neurol. 2024. PMID: 39286801 Free PMC article. Review. - Thoracic Intervertebral Disc Herniation Associated With Chronic Anabolic Androgenic Steroid Use: A Case Report.
Cleri NA, Zhang J, Singh G, Mikell CB, Pendleton C. Cleri NA, et al. Cureus. 2024 Jun 15;16(6):e62438. doi: 10.7759/cureus.62438. eCollection 2024 Jun. Cureus. 2024. PMID: 39011187 Free PMC article. - Biochemical liver damage during gender affirming therapy in trans adults assigned female at birth: a meta-analysis.
Tienforti D, Savignano G, Spagnolo L, Di Giulio F, Baroni MG, Barbonetti A. Tienforti D, et al. J Endocrinol Invest. 2024 Jun 22. doi: 10.1007/s40618-024-02418-y. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38909133
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources